Antares Pharma $ATRS is one expensive stock

But being in the healthcare sector and a small-cap, how great is this stock and what opportunity does it provide for investors?

Let’s find out (Thread)

First, the company has impressive revenue growth!

Overall revenue increased 42% YoY and they’ve achieve record revenue overall.

A sign that it’s a growth stock $ATRS

It’s flagship drug, XYOSTED, continues to garner huge growth

$ATRS

EpiPens are a product in huge demand and are really expensive

Selling the pens for generic version of the EpiPen makes this company unique in its own way

$ATRS $TEVA

To give more background on what Antares Pharma does with Teva, it basically gives the devices for those drugs

And we’re talking about the devices used to distribute the drug

$TEVA $ATRS

And the company continues to do more and more business deals

$ATRS

Overall, the business goes like this:

As revenue increases, losses decrease

That shows that $ATRS is experiencing the benefits of economies of scale